Observational study finds blood pressure variability increases death risk in type 2 diabetes — Evidence Review
Published by researchers at Amsterdam University Medical Centre
Researched by
— the AI search engine for science
Table of Contents
People with type 2 diabetes who have highly variable systolic blood pressure face a nearly threefold increased risk of death compared to those with normal blood sugar and steadier readings, according to a new observational study. Previous research generally supports these findings, showing that blood pressure variability is a significant risk factor for mortality and cardiovascular events.
- Multiple meta-analyses and clinical trials have found that long-term variability in blood pressure is associated with higher risks of all-cause mortality, cardiovascular events, and stroke, both in the general population and specifically among people with type 2 diabetes 1 3 4.
- Prior studies also support that blood pressure variability offers prognostic information beyond average blood pressure levels, and that its impact is independent of baseline risk and other common risk factors 1 3 4.
- Evidence suggests that intensive blood pressure control reduces cardiovascular risk in people with diabetes, but the benefits of targeting blood pressure variability specifically, and how to manage it in clinical practice, remain areas for further research 5 13 14.
Study Overview and Key Findings
Fluctuations in blood pressure across clinic visits are often overlooked in routine care, yet this study highlights their potential importance, especially in people with type 2 diabetes. The research, led by Dr. Fariba Ahmadizar and colleagues at Amsterdam University Medical Centre, analyzed data from over 57,000 UK Biobank participants. The findings suggest that blood pressure variability may be a key marker for identifying individuals at higher risk of death or stroke, particularly when combined with dysregulated blood sugar.
| Property | Value |
|---|---|
| Organization | Amsterdam University Medical Centre |
| Authors | Fariba Ahmadizar |
| Population | People with type 2 diabetes and blood pressure variability |
| Sample Size | n=57,611 |
| Methods | Observational Study |
| Outcome | Death risk, stroke incidence, blood pressure variability |
| Results | Type 2 diabetes with high variability had 2.8x death risk. |
The study's importance lies in its focus on blood pressure variability—a factor not routinely used in clinical risk assessment. Over a median follow-up of 5.1 years, participants with both type 2 diabetes and high systolic blood pressure variability were nearly three times as likely to die as those with normal blood sugar and low variability. The study also found that greater blood pressure swings in all measured parameters (systolic, diastolic, mean arterial, and pulse pressure) were associated with higher mortality, independent of average blood pressure or diabetes status. These associations remained after accounting for other risk factors.
While the absolute risk of death over 10 years was estimated at 1.0% for people with normal blood sugar and low variability, it rose to 2.9% for those with type 2 diabetes and high variability. The study does not establish a causal relationship, but it raises important questions about the potential value of monitoring blood pressure variability in routine diabetes care.
Literature Review: Related Studies
To place these findings in context, we searched the Consensus database—covering over 200 million papers—using the following search queries:
- blood pressure variability mortality risk
- type 2 diabetes stroke risk factors
- high blood pressure outcomes diabetes patients
Below is a synthesis of major themes from the literature, summarized in a topic table, followed by more detailed explanations.
| Topic | Key Findings |
|---|---|
| How does blood pressure variability affect mortality and cardiovascular risk? | - Higher long-term blood pressure variability is linked to increased risk of death and cardiovascular events, independent of mean blood pressure 1 3 4 5. - This association holds across different populations and settings. |
| What is the relationship between blood pressure management and outcomes in diabetes? | - Lowering blood pressure in type 2 diabetes patients improves mortality and reduces cardiovascular risk, especially when baseline systolic BP is ≥140 mmHg 11 13 14. - Both high and low BP levels may increase risk 15. |
| Are people with type 2 diabetes at greater risk of stroke and death? | - Diabetes independently increases risk of stroke and mortality, with risk further amplified by hypertension and blood pressure variability 6 7 8 9 10. - Good control of risk factors can reduce excess risk 6. |
| Is blood pressure variability clinically actionable in current practice? | - Blood pressure variability is not yet routinely used in clinical guidelines, due to methodological challenges and need for further research 5. - Evidence is growing for its prognostic value, but standardization is lacking. |
How does blood pressure variability affect mortality and cardiovascular risk?
Several large studies and meta-analyses demonstrate that higher variability in blood pressure readings over time is consistently associated with increased risk of all-cause mortality and cardiovascular events, including stroke and coronary disease, regardless of the average blood pressure level 1 3 4 5. These associations have been observed in both general hypertensive populations and among individuals with diabetes.
- Blood pressure variability provides risk prediction beyond mean blood pressure values 1 3 4.
- The prognostic significance of blood pressure variability is similar in magnitude to established risk factors such as cholesterol 4.
- Both systolic and diastolic variability are important, but most evidence points to systolic variability as the stronger predictor 1 3 4.
- These relationships are independent of other risk factors, including glycemic control and kidney function 3.
What is the relationship between blood pressure management and outcomes in diabetes?
Lowering blood pressure in patients with type 2 diabetes is strongly associated with improved clinical outcomes, including reduced mortality, fewer cardiovascular events, and less microvascular damage 11 13 14. However, both excessively high and low blood pressure levels may increase risk, especially in people with diabetes.
- Blood pressure lowering is most beneficial when baseline systolic BP is ≥140 mmHg; further lowering below 130 mmHg may not provide additional benefit and may increase risk in some populations 12 13 15.
- Intensive blood pressure control (targeting <120 mmHg) reduces major vascular events in high-risk patients, including those with diabetes, though some increased risk of adverse effects is noted 14.
- The relationship between achieved blood pressure levels and outcomes is non-linear, with higher risks at both high and low extremes 15.
- Renin-angiotensin system blockers may be particularly beneficial for people with diabetes 13.
Are people with type 2 diabetes at greater risk of stroke and death?
Multiple cohort studies confirm that people with type 2 diabetes have higher risks of stroke, cardiovascular events, and mortality compared to the general population, and that hypertension is a key modifiable contributor to this excess risk 6 7 8 9 10.
- The risk of stroke is 1.5-2 times higher in people with diabetes, with additional risk conferred by hypertension and poor glycemic control 8 9.
- Good management of all major risk factors (including blood pressure, cholesterol, glycemic control, and smoking) can reduce or even eliminate excess cardiovascular risk 6.
- Blood pressure variability further amplifies risk for adverse outcomes in people with diabetes 3.
- Age, prior stroke, and microvascular complications are important predictors of stroke in diabetes 7 10.
Is blood pressure variability clinically actionable in current practice?
Despite strong evidence linking blood pressure variability to adverse outcomes, it is not yet part of standard risk assessment or management guidelines, largely due to methodological challenges and lack of standardized measurement 5.
- Blood pressure variability is recognized as a potential cardiovascular risk factor, but further research is needed to determine if interventions to reduce variability improve outcomes 5.
- The European Society of Hypertension and other expert groups have called for standardization of measurement methods and further investigation into clinical applications 5.
- Current clinical recommendations focus on mean blood pressure, not variability, but this may change as evidence accumulates 5.
- Observational studies, including the new one discussed here, underline the need for randomized trials to test whether targeting variability, in addition to mean blood pressure, offers benefit 5.
Future Research Questions
While the new study adds to the growing evidence that blood pressure variability is a significant risk factor—especially in people with type 2 diabetes—several important questions remain. Further research is needed to clarify the mechanisms, clinical utility, and potential interventions related to blood pressure variability.
| Research Question | Relevance |
|---|---|
| Can targeted interventions to reduce blood pressure variability in people with type 2 diabetes lower the risk of death and stroke? | Randomized trials are needed to determine whether reducing blood pressure variability, rather than just average blood pressure, leads to better outcomes in people with diabetes 3 5. |
| What are the most accurate and practical methods for assessing blood pressure variability in clinical practice? | Standardized, feasible approaches are needed for measuring blood pressure variability reliably across diverse clinical settings, as current methods are heterogeneous and underutilized 5. |
| Does blood pressure variability predict risk of other complications in type 2 diabetes beyond stroke and death? | Investigating whether blood pressure variability is linked to microvascular complications, heart failure, or cognitive decline could help broaden its clinical relevance 3 4 5. |
| How do lifestyle and medication choices influence blood pressure variability in patients with type 2 diabetes? | Understanding modifiable contributors to blood pressure variability may inform more effective prevention and management strategies for high-risk groups 1 3 5. |
| Is there a threshold of blood pressure variability above which risk increases markedly, and can this be used to guide clinical decisions? | Identifying clinically meaningful thresholds could help incorporate blood pressure variability into risk stratification and treatment planning in diabetes care 1 3 4 5. |
This article presents an evidence-based synthesis of current research on blood pressure variability, mortality, and stroke risk in people with type 2 diabetes, highlighting both consensus and ongoing uncertainties in the field.